Dermalogica Concealing Spot Treatment
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Soufre | 5 % |
Non-medicinal ingredients
Butylène glycol, Silice, Dioxyde de titane, Alcool cétéarylique, Camphre, PEG-40 Hydrogenated Castor Oil, Caféine, Gomme de xanthane, Ethylhexylglycérine, Aesculus hippocastanum, Lauryl PEG/PPG-18/18 Methicone, Sarcosine, Acide salicylique, Ceratonia Siliqua, Phénoxyéthanol, Oxyde de zinc, Panthenol, Alun de potassium, Eau, Silica Dimethyl Silyate, Glycyrrhizinate d'ammonium, Extrait d'écorce de cinnamomum zeylanicum, Oxydes de fer, Glycérine, Niacinamide, Biotine, Hamamélis, extrait de levure, Ceteareth-20, Gluconate de zinc, Diméthicone, Trisiloxane d'éthyle, Montmorillonite, Capryloyl Glycine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps clear up acne pimples. Upon contact concentrated Sulfur helps keep skin clear of acne pimples and helps prevent new acne pimples from forming.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Dermalogica (Canada) Inc.
- NPN or DIN-HM
- 80009101
- Status
- Inactive licence
- Licence date
- 13 January 2009
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80009101
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Dermalogica Concealing Spot Treatment”, https://compoatlas.com/en/supplements/canada/80009101-dermalogica-concealing-spot-treatment, updated 13 January 2009.